In our pharmacy which of the following activities are allowed niosh
Joint Position Statement from the Oncology Nursing Society and the Hematology/Oncology Pharmacy AssociationHazardous drugs (HDs) are chemicals that demonstrate one or more of the following characteristics: carcinogenicity, genotoxicity, teratogenicity, reproductive toxicity, or organ toxicity. In addition, newer drugs with a structural or toxicity profile that mimics an agent known to be hazardous by one of the aforementioned criteria should also be treated as HDs (National Institute for Occupational Safety and Health [NIOSH], 2016). Any HD-handling activity can expose healthcare workers (HCWs), as documented in a multitude of case reports and studies. HD exposure is associated with acute symptoms (e.g., nasal sores, hair loss, skin rash), adverse reproductive outcomes (e.g., miscarriage), genetic changes (e.g., chromosomal aberrations, sister-chromatid exchanges), and an increased occurrence of cancer (Centers for Disease Control and Prevention [CDC], 2019). Show
The Occupational Safety and Health Administration (1986) acknowledged the occupational risks of HDs and issued recommendations for their safe handling more than 30 years ago, and updated guidelines from NIOSH and professional societies have been published (NIOSH, 2016; Polovich & Olsen, 2018; Power & Coyne, 2018). All guidelines address the need for HD-related policies and procedures, education and training, and safe handling precautions in settings in which HDs are present. Safe handling precautions include the use of engineering controls, safe work practices, and personal protective equipment (PPE). When used appropriately and consistently, recommended precautions reduce occupational HD exposure (NIOSH, 2004). It is the position of the Oncology Nursing Society and Hematology/Oncology Pharmacy Association that:
Approved by the Oncology Nursing Society Board of Directors, July 2019. Approved by the Hematology/Oncology Pharmacy Association Board of Directors, August 2019. Revised October 2021, March 2022. Download this position statement. Statement TypeNursing Practice ReferencesCenters for Disease Control and Prevention. (2019). Occupational exposure to antineoplastic agents and other hazardous drugs: Recent publications, guidelines, review articles and surveys. http://www.cdc.gov/niosh/topics/antineoplastic/pubs.html Connor, T.H., & McDiarmid, M.A. (2006). Preventing occupational exposures to antineoplastic drugs in health care settings. CA: A Cancer Journal for Clinicians, 56(6),354–365. https://doi.org/10.3322/canjclin.56.6.354 National Institute for Occupational Safety and Health. (2004). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Centers for Disease Control and Prevention. http://www.cdc.gov/niosh/docs/2004-165 National Institute for Occupational Safety and Health. (2016). NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. Centers for Disease Control and Prevention. https://www.cdc.gov/niosh/docs/2016-161 Polovich, M., & Olsen, M. (2018). Safe handling of hazardous drugs (3rd ed.). Oncology Nursing Society. Power, L.A., & Coyne, J.W. (2018). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 75(24), 1996–2031. https://doi.org/10.2146/ajhp180564 U.S. Pharmacopeial Convention. (2016). USP General Chapter <800>: Hazardous drugs— Handling in healthcare settings. https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare What are the NIOSH categories?The NIOSH criteria include : carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low doses, and drugs that mimic existing drugs in structure or toxicity.
What is the NIOSH hazardous drug list?The NIOSH List is an aid designed to enable employers to identify which drugs handled by employees are considered by NIOSH to be hazardous drugs. Because new drugs and new formulations are continuously brought to market between NIOSH's periodic updates hazardous drug evaluation should be a continual process.
How do you handle NIOSH drugs?When possible, avoid cutting, crushing, or otherwise manipulating pills or capsules. This might produce powder that can contaminate a workplace and may expose workers. When manipulating hazardous drugs, use effective engineering controls and personal protective equipment.
What are the 3 risk groups for hazardous drugs?Pharmaceuticals as Workplace Hazards
Group 1 is antineoplastic drugs (roughly, chemotherapy medications). Group 2 is other drugs (not antineoplastic) that are hazardous, while Group 3 are drugs that may interrupt fertility in women or men or that may get into breast milk.
|